Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹78 Cr
Revenue (TTM)
₹148 Cr
Net Profit (TTM)
₹8 Cr
ROE
7.6 %
ROCE
10.9 %
P/E Ratio
9.7
P/B Ratio
1
Industry P/E
20.87
EV/EBITDA
5.2
Div. Yield
1.3 %
Debt to Equity
0.4
Book Value
₹36.7
EPS
₹3.9
Face value
10
Shares outstanding
20,520,723
CFO
₹77.50 Cr
EBITDA
₹77.26 Cr
Net Profit
₹31.08 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Archit Organosys
| -10.8 | -2.6 | -10.9 | -5.6 | -14.3 | 9.0 | 9.2 |
|
BSE Commodities
| -4.9 | -8.2 | -6.3 | 5.0 | 15.1 | 11.3 | 15.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Archit Organosys
| -9.5 | -12.5 | -35.5 | 104.2 | 87.7 | 99.2 | -62.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Archit Organosys
|
38.1 | 78.1 | 147.6 | 8.0 | 6.7 | 11.3 | 9.7 | 1.0 |
| 1,319.0 | 6,741.6 | 1,535.0 | 180.7 | 13.7 | 12.7 | 37.3 | 4.5 | |
| 3,311.0 | 14,345.1 | 15,069.6 | 378.2 | 3.0 | 9.9 | 37.9 | 3.7 | |
| 992.8 | 12,600.4 | 11,162.0 | 877.2 | 12.4 | 13.7 | 14.4 | 1.9 | |
| 1,655.3 | 5,861.9 | 5,078.5 | 280.8 | 7.1 | 11.9 | 20.9 | 2.3 | |
| 603.5 | 4,422.4 | 4,308.2 | 34.3 | 0.0 | -0.2 | -- | 0.8 | |
| 2,438.8 | 7,826.3 | 15,622.2 | 1,787.5 | 16.6 | 12.6 | 8.7 | 1.0 | |
| 4,192.6 | 5,717.1 | 1,886.6 | 168.0 | 11.4 | 16.6 | 34 | 4.3 | |
| 5,891.0 | 30,150.3 | 3,077.1 | 545.9 | 25.9 | 18 | 55.2 | 8.0 | |
| 651.9 | 16,625.4 | 14,655.0 | 194.0 | 4.8 | 1.2 | 92.4 | 0.7 |
No Review & Analysis are available.
Archit Organosys Limited manufactures and sells chemical products in India. Its products comprise monochloro acetic acid, sodium monochloro acetate, chloroacetyl chloride, and polyaluminium chloride; and pigments and specialty derivatives, as well as... adhesives and sealants under the AOL brand. The company's products are used in the synthesis of various agricultural chemicals, cosmetic surfactants, oil drilling chemicals, plastic additives, etc. Archit Organosys Limited also exports its products to the United States, Europe, the Middle East, and other countries. The company was formerly known as Shri Chlochem Limited and changed its name to Archit Organosys Limited in May 2012. Archit Organosys Limited was founded in 1989 and is based in Ahmedabad, India. Read more
Incorporated
1993
Chairman
Kandarp K Amin
Managing Director
--
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Archit Organosys Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Archit Organosys Ltd is ₹38.05 (BSE) as of 02-Apr-2026 IST. Archit Organosys Ltd has given a return of -14.27% in the last 3 years.
The P/E ratio of Archit Organosys Ltd is 9.73 times as on 02-Apr-2026, a 53 discount to its peers’ median range of 20.87 times.
The P/B ratio of Archit Organosys Ltd is 1.04 times as on 02-Apr-2026, a 31 discount to its peers’ median range of 1.51 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
15.19
|
1.11
|
|
2024
|
27.10
|
1.38
|
|
2023
|
10.92
|
2.01
|
|
2022
|
9.73
|
1.54
|
|
2021
|
7.43
|
0.95
|
The 52-week high and low of Archit Organosys Ltd are Rs 51.45 and Rs 34.00 as of 03-Apr-2026.
Archit Organosys Ltd has a market capitalisation of ₹ 78 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Archit Organosys Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.13
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.